Steranios 20 Concentre DS-AE
Steranios 20 Concentre DS-AE
10%, i.e.
• SPORICIDAL:
10 minutes - NF T 72-230/231
250 ml for 2.5 l 2%
1 hour for spores
500 ml for 5 l
Pavé du Moulin
59260 Lille-Hellemmes • France
Tel : + 33 3 20 67 67 67
Fax : + 33 3 20 67 67 68
STERANIOS 20% Concentré is recommended for the cold sterilization of surgical and
medical instruments, and for the disinfection of endoscopic equipment and thermo
sensitive equipment.
Clean and rinse thoroughly medical devices before soaking in the STERANIOS 20%
Concentré bath.
STERANIOS 20% Concentré has to be diluted before use with good microbiological
quality water. Water softening is recommended in order to avoid white deposits of
limestone.
Révisé le 26/05/2008
Revised on 26/05/2008
STERANIOS 20% Concentré has the EC mark 0459 relating to medical devices in
accordance with the 93/42/EC Directive, class II a.
STERANIOS 20% Concentré is referred since 1996 in the disinfectant positive list
issued by SFHH, French Association for Hospital Hygiene.
Révisé le 28/05/2007
Reviewed on 28/05/2007
182_FIRG
Autres ingrédients
Other ingredients
Agent stabilisant
Stabilising agent
Colorants
Colouring agents
Excipients
Excipients
182_Révisé le 08/06/2007
182_Reviewed on 08/06/2007
Produit dilué
Dilution : 5% - 50 ml par litre d'eau ou 10% - 100 ml par litre d'eau
- Stabilité du bain d’immersion :
- 30 jours.
- 7 jours, selon la réglementation française
Remplacement du bain de STERANIOS 20 % Concentré en cas de
présence de souillures
Diluted product
Dilution: 5% - 50 ml per liter of water or 10% - 100mL per liter of water
- Stability of soaking bath
- 30 days.
- 7 days, according to the French regulation
Replacement of the bath of STERANIOS 20 % Concentré in the event of the presence of
stains
Révisé le 28/05/2007
Revised on 28/05/2007
Remarque
Le colorant vert menthe (E102 - E131) est sensible à la lumière.
En cas de surexposition, la solution diluée, ou le produit concentré peut
se décolorer sans entraîner une perte d'activité.
Note
The dye « Vert Menthe » (E102 – E131) is sensitive to the light.
In the event of over exposure, the diluted solution, or the concentrated product can be faded
without involving a loss of activity
Révisé le 28/05/2007
Revised on 28/05/2007
Résultats
Results
EN 1040 2% 5 min.
Conditions de
EN 13727 0,1 % 60 min.
propreté
0,5 % 5 min.
Clean conditions
EN 14348 :
Mycobacterium terrae 5% 10 min.
< 2,5 % 60 min.
Mycobacterium avium 10 % 60 min
EN 1275 5% 5 min.
NF EN 13624
Candida albicans 0,5 % 60 min.
2,5 % 5 min.
Aspergillus niger 5% 10 min.
Résultats
Results
Etudes Concentration Temps de Conditions
Studies active contact spécifiques
Active concentration Contact time Specific conditions
VIRUCIDIE Virucidal activity
NF T 72-180 5% 10 min.
2,5 % 30 min.
laboratoi res
AN l OS
Laboratoire de microbiologie
ESSAIS
ACCREDITATION
N°l-0139
CP
Responsa icrobiologie Pharmacien Re; )nsable Microbiologie
Microbi
>
'onager Pharma r
obiology Manager
L'essai a été réalisé selon la méthode d'essai décrite dans la norme européenne
EN 1040 « Antiseptiques et désinfectants chimiques - Activité bactéricide de
base».
Détermination de l'activité bactéricide dans les conditions de laboratoire définies
par la présente norme européenne.
The test was realised according to the test method described in the
European standard EN 1040 « Antiseptics and chemical disinfectants».
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batchnumber : W092 14
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test temperature : 20°C ± 1°C
Temps de contact
Contact time : 5 minutes + 10s
Gélose de dénombrement
Counting agar : Tryptone soja agar
Pour les deux souches soumises à l'essai - For the both strains to be tested
N est compris entre 1,5 x 108 UFC/ml et 5 x 108 UFC/ml
is comprised between 1.5x10* CFU/ml and 5x10* CFU/ml
Nv est compris entre 6 x 102 UFC/m! et 3 x 103 UFC/ml
is comprised between 6 x 10* CFU/ml and 3x10* CFU/ml
NX est supérieur OU égal à 0,05 X Nv - ¿s higher or equal to 0.05 x Nv
NY est Supérieur OU égal à 0,05 X Nv- ¿s higher or equal to 0.05 x Nv
La neutralisation est validée avec (a méthode de filtration pour la concentration d'essai de 2% du produit
STERANIOS 20 % et pour les souches soumises à l'essai.
The neutralization is validated with theßltration method for the 2% test concentration of the product
STERANIOS 20% and the strains tested.
Conclusion :
F.
Responsable La tai|^'de Microbiologie Pharmacien R able Microbiologie
biology ry Mariager Pharmaci biology Manager
The test was realised according to the test method described in the European
standard EN 13727 « Chemical disinfectants and antiseptics- Quantitative
suspension test for the evaluation of bactericidal activity of chemical
disinfectants for instruments used in the medical area (phase 2 /Etape 1) ».
Determination of the bactericidal activity in the laboratory conditions defined
in the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 043-17
Fabricant
Manufacturer : LABORATOIRES AN IOS
Checking of the method and validation of the method by filtration for the
O,5 % test concentration of the product STERANIOS 20% to be tested.
Pseudomonas aeruginosa 2,1 108 2,1 107 8,9 102 8,9 101 9,9 101 1,1 102 1,0 102
Enterococcus hirae 1.9 108 1.9107 3,910 2 3,9101 5,8101 6,3101 6,2101
Staphylococcus aureus 2,810a 2,8107 8,9102 8,9 101 1,1 102 1.3 10Z 1,4102
Pseudomonas aeruginosa < 3,8 log > 5,1 loa > 5,1 log
Enterococcus hirae < 3,8 log > 5,1 loa > 5,1 log
Staphylococcus aureus < 4,0 log > 5,1 loa > 5,1 log
Conclusion :
C.Pluc
Responsable Labö e Microbiologie Pharmacien nsable Microbiologie
Microbiology Manager Pharmaci biology Manager
The test was realised according to the test method described in the European
standard EN 13727 « Chemical disinfectants and antiseptics- Quantitative
suspension test for the evaluation of bactericidal activity of chemical
disinfectants for instruments used in the medical area (phase 2 /Etape 1) ».
Determination of the bactericidal activity in the laboratory conditions defined
in the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 043-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Checking of the method and validation of the method by flltration for the
1% test concentration of the product STERANIOS 2O% to be tested.
Nombre de cellules viables (UFC/ml)
Suspension Suspension Validation Suspension Validation des Témoin de Essai de
filtration sur
Souches test d'essai d'essai/10 suspension de validation conditions l'inactivation
membrane
bactérienne /10 expérimentale par filtration
Tested strains Validation Expérimenta sur
Bacterial test Bacterial test Validation l conditions membrane
suspension suspension bacterial
bacterial Experimental control
suspension conditions Method
suspension validation
/10
N No NV B
NVO
Pseudomonas aeruginosa 2,1 108 2,1 107 8,9 102 8,9 101 9,9 101 1,1 1,0 102
Enterococcus hirae 1.9 108 1.9 107 3,9 102 3,9 101 5,8 101 6,3 101 6,2 101
Staphylococcus aureus 2,8 108 2,8 107 8,9 102 8,9 101 1,1 102 1.3 1(T 1,4 102
Pseudomonas aeruginosa < 3,8 log > 5,1 loq >5,1 log
Enterococcus hirae < 3,8 log < 3,8 log > 5,1 loq
Staphylococcus aureus < 4,0 log 5,1 log > 5,3 loq
Conclusion :
Laboratory:
Extension: 251
Ref : JCD/VLJ/92004
SUBJECT OF REQUEST:
HEADS OF RESEARCH
Industrial Unit:
13, rue Lavoisier
92023 NANTERRE Cedex
Switchboard: +33 (0)1 47 29 13 13
Fax: +33 (0)1 47 25 36 02
Telex: 613 252 F SOLU AP
The test was conducted in compliance with the protocol described in French standard NF T
72171: Water-miscible antiseptics and disinfectants used in liquid state.
Determination of bactericidal activity in presence of interfering substances, (spectrum 4).
Membrane filtering method.
SAMPLE IDENTIFICATION
TEST CONDITIONS
Product diluent:
Neutralisation: 300 ml distilled water, to which 1 % tween 80 and 100 ml water was added
PRELIMINARY TEST
Key:
N: inoculum test; N': filtering reference; n': filtering test.
ACTUAL TEST
X
Concentration in % (v/v) in contact with bacteria
Strains N N' n'
0.25 0.5 1 2 2.5 min pH max pH
Pseudomonas aeruginosa
157 175 173 0 0 0 0 0 6.4 7
CIP A 22
Escherichia coli
222 225 180 70 19 1 0 0 6.4 7
CIP 54 127
Staphylococcus aureus
264 245 174 5 0 0 0 0 6.4 7
CIP 53154
Enterococcus hirae
196 184 178 + 15 0.5 0 0 6.4 7
CIP 5 855
CONCLUSION
The "STERANIOS 20% Concentré" product has bactericidal activity, spectrum 4, in presence
of interfering substances (Albumin 1%, hard water at 30°F) according to standard AFNOR
NF T 72171 when diluted at 5% (v/v).
PHARMACIE CENTRALE
DES HÔPITAUX DE PARIS
Siège Social
7, rue du Fer-à-Moulin BP 09
75221 PARIS Cedex 05
Standard: 33 (1)43 37 11 00
Télécopie: 33 (1)43379597
Télex : 204 203 F PHARMAP
(novembre 88).
RESPONSABLES DE L'ETUDE
Unité Industrielle :
13. rue Lavoisier
92023 NANTERRE Cedex
Standard: 33 (1)4729 13 13
Télécopie: 33 (1)47 25 36 02
Télex:613252FSOLUAP
PRINCIPE
L'essai a été réalisé selon le protocole décrit dans la norme française homologuée
NF T 72171 : Antiseptiques et désinfectants utilisés à l'état liquide, miscibles à l'eau.
(spectre 4).
IDENTIFICATION DE L'ECHANTILLON
CONDITIONS OPERATOIRES
Diluant du produit :
distillée.
ESSAI PRELIMINAIRE
CIPA 22
2,5 % Escherichia coli 222 225 180
CIP 54 127
2,5 % Staphylococcus aureus 264 245 174
CIP 53154
2,5 % Enterococcus hirae 196 184 178
CIP 5 855
Interprétation :
X
1
Souches N N n' concentration en % (v/v) au
contact avec les bactéries
CIP A 22
Escherichia coli 222 225 180 70 19 1 0 0 6,4 7
CIP 54 127
Staphylococcus aureus 264 245 174 5. 0 0 0 0 6,4 7
CIP 53154
Enterococcus hirae 196 184 178 + la 0,5 0 0 6,4 7
CIP 5855
Responsables de l'étude:
FyDurarfd
Responsable icrobiologie Pharmacien Responsable Microbiologie
SrV^
Microbiol Manager Pharmacist,microbiology Manager
Laboratoires ANIOS
Pavé du Moulin - 59260 Lille-Hellemmes
Tél. +33 3 20 67 67 67 - Fax : +33 3 20 67 67 68
Siret N° 458 501 921 00043 - SA au capital de 232.800 €
L'essai a été réalisé selon la méthodologie d'essai décrite dans la norme européenne EN
14348 «Antiseptiques et désinfectants chimiques ».Essai quantitatif de suspension
pour l'évaluation de l'activité mycobactéricide des désinfectants chimiques utilisés en
médecine y compris la désinfection des instruments .Phase 2 - Etape 1.
Détermination de l'activitén tuberculocide dans les conditions de laboratoire définies par
la présente norme européenne.
The test was realised according to the test method described in the European
standard NF EN 14348 « Chemical disinfectants and antiseptics-Quantitative
suspension test for the evaluation of mycobactericidal activity of chemical
disinfectant in the medical area including instrument disinfectants ». Phase 2
- Etape 1
Determination of the tuberculocidal activity in laboratory conditions defined
by the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 053-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test température : 20°C ± 1°C
Temps de contact
Contact time : 10 et 60 minutes! 10s
Diluant du produit lors des essais : eau dure
Diluent of the product used during the test : hard water
Apparence du produit et de ses dilutions : préparation physiquement homogène
et stable pendant l'essai
Appearence product dilutions : Preparation physically
homogeneous and stable during test
Souche testée (Strain tested) : Mycobacterium terrae ATCC1S755
Substance ¡nterferente : Albumine bovine à 0.3 g/l.
Interfering substance : 0.3 g/l BSA
B
N
Mycobacterium terrae 1.510 9 1.5 108 8.2 101 7.6101 8.1 101 7.5101
60 minutes
Nombre de cellules viables (UFC/ml) pour le mélange d'essai
Souche-test (Na) pour les concentrations de : %(v/v)
Tested strain Number of the viable cells (CFU/ml)for the test mixture
(Na) for the concentrations of: %(v/v)
2.5 5.0 10
10 minutes
Nombre de cellules viables (UFC/ml) pour le mélange d'essai
Souche-test (Na) pour les concentrations de : %(v/v)
Tested strain Number of the viable cells (CFU/ml)for the test mixture
(Na) for the concentrations of : %(v/v)
2.5 5.0 10
Conclusion :
Conformément à la norme NF EN 14348 ( juin 2005), STERANIOS 20% dilué (v/v) dans
de l'eau dure à une concentration G 2.5% , présente une activité tuberculocide en 60
minutes de contact à 20 °C et dilué à 5% présente une activité tuberculocide en 10
minutes de contact à 20 °C en condition de propreté vis-à-vis de la souche de référence
: Mycobacterium terrae ATCC 15755
In compliance with the European standard NF EN 14348 ( juin 2005),
STERANIOS 2O% diluted at concentration £ 2.5% (v/v) in hard water ,
presents a tuberculocidal activity in a 6O minute contact time at 20 °C and
diluted at 5% presents a tuberculocidal activity in 10 minute in clean
condition, against the referenced strain of: Mycobacterium terrae ATCC
15755.
Study n°19797GB
Responsables de l'étude:
C.PIucbart F. Dufaiid
Respon "Labjafatojérde-Mcrobiologie Pharmacien Responsable Microbiologie
Microbio itçry Manager Pharmacist Jmcriomology Manager
Laboratoires ANIOS
Pavé du Moulin • 59260 Lille-Hellemmes
Tél. +33 3 20 67 67 67 - Fax : +33 3 20 67 67 68
Siret N° 458 501 921 00043 - SA au capital de 232.800 €
The test was realised according to the test method described in the European
standard NF EN 14348 « Chemical disinfectants and antiseptics-Quantitative
suspension test for the evaluation of mycobactericidal activity of chemical
disinfectant in the medical area including instrument disinfectants ». Phase 2
- Etape 1
Determination of the mycobactericidal activity in laboratory conditions
defined by the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 053-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test temperature : 20°C + 1°C
Temps de contact
Contact time : 60 minutes ± 10s
Diluant du produit lors des essais : eau dure
Diluent of the product used during the test : hard water
Apparence du produit et de ses dilutions : préparation physiquement
homogène et stable pendant l'essai
Appearence product dilutions : Preparation physically
homogeneous and stable during test
Mycobacterium avium 2.2 109 2.2 108 1.3102 1.4 102 1.4102 1.3 102
Conclusion :
Responsables de l'étude:
F. Qdraifd
Respori; Microbiologie Pharmacien Restónsable Microbiologie
Microbiology ry Manager Pharmacis^Microbiology Manager
Laboratoires ANIOS
Pavé du Moulin - 59260 Lille-Hellemmes
Tél. +33 3 20 67 67 67 - Fax : +33 3 20 67 67 68
Siret N° 458 501 921 00043 - SA au capital de 232.800 €
The test was realised according to the test method described in the project of
the European standard EN 14563 "Chemical disinfectants and antiseptics-
Quantitative carrier test for the evaluation of mycobactericidal or
tuberculocidal activity of chemical disinfectants used for instruments in the
medical area - Phase 2 Step 2 " .
Determination of the mycobactericidal activity in laboratory conditions
defined by the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 053-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test température : 20°C ± 1°C
Temps de contact
Contact time : 10 minutes ± 10s
Diluant du produit lors des essais : eau dure
Diluent of the product used during the test : hard water
Apparence du produit et de ses dilutions : préparation physiquement
homogène et stable pendant l'essai
Appearence product dilutions : Preparation physically
homogeneous and stable during test
N NVO B NW
Mycobacterium terrae 1.9 109 6.8 101 6.8 101 6.0 101 6.6 101 1.6107
Conclusion :
Conformément à la norme prEN 14563 (mai 2005), STERANIOS 20% dilué (v/v)
dans de l'eau dure, présente une activité tuberculocide en 10 minutes de contact
à 20 °C à la concentration de 5% en condition de propreté pour la désinfection
des instruments vis-à-vis de la souche de référence : Mycobacterium terrae .
Principle:
The Bactec TB medium (12B) is a an enriched basal Middlebrook 7H9 medium. The
mycobacterium use a 14C-labeled fatty acid present in the medium and release 14C02 into the
atmosphere.
When mycobacterial growth occurs in the 12B flasks, the Bactec 460 measures the rate of
radioactivity (due to the 14C02 released) and translates it into numerical format on a scale of 0
to 999.
These values are designated a Growth Index (GI). The GI increases proportionally to the
number of bacteria.
After action of the disinfectant with the Mycobacterium tuberculosis suspension, the
remaining Mycobacteria are counted by injecting each diluted germ suspension into one or
two 12B flasks. An increase in the GI corresponds to the presence of Mycobacteria.
This technique is simple. It minimises risks for the operator and the risk of contaminating
culture medium is virtually nil.
Methods:
1) Inoculum count
Preparation of a suspension with 100 mg /ml sterile distilled water using a pure culture of
Mycobacterium tuberculosis on Coletsos medium.
At the end of the contact time, add 35 ml sterile distilled water, shake and centrifuge 30
minutes at 3,000 T/ minute.
5) Culturing
After centrifugation, remove the supernatant. Rework the centrifugation pellet with 2 ml
sterile distilled water (dilution at 1/10).
- incubate at 37° for 21 days, recording the Bactec TB’s GI reading regularly.
6) Interpretation reading
Conclusion:
Matériel
pH : 3,08
Bactec 460 (Becton Dickinson)
Milieu de culture liquide : Milieu Middelbrook 7H12
Mycobacterium tuberculosis hominis (souche provenant d'un malade).
Principe
Le milieu Bactec TB (12B) est un milieu de base Middelbrook 7H9 enrichi. Les mycobactéries utili-
sent un acide gras marqué au 14C présent dans le milieu et libèrent du 14CÛ2 dans l'atmosphère.
S'il y a croissance de mycobactéries dans les flacons de 12B, le Bactec 460 mesure le taux de radio-
activité (due au 14CÛ2 dégagé) et le traduit sous forme numérique sur une échelle allant du 0 à 999.
Ces valeurs sont désignées index de croissance (Grouwth indice = GI). L'augmentation du GI est pro-
portionnelle au nombre de bactéries.
Après action du désinfectant avec la suspension de Mycobacterium tuberculosis on numere les My-
cobactéries restantes en injectant chaque dilution de suspension de germes dans un ou deux flacons
12B. L'élévation du GI correspond à la présence de Mycobactéries.
La technique est simple, diminue le risque pour le manipulateur, et le risque de contamination des
milieux de culture est quasi nulle.
Méthodes :
1) Numération de l'inoculum
Préparation d'une suspension à 100 mg /ml en eau distillée stérile à partir d'une culture pure de
Mycobacterium tuberculosis sur Coletsos.
A partir de cette solution "mère", effectuer des dilutions de 10 en 10 jusqu'à 10"^.
-1 206 999
-2 9 459 999
-4 3 3 3 13 51 155 999
-7 3 2 5 0 1 0 1 1 8 11 60 561 999
-8 3 1 2 0 0 1 1 1 2 0 1 0 0
-9 2 2 1 0 0 0 1 2 1 0 1 0 2
-1 0 4 8 22 71 203 999
-4 0 1 0 1 0 1 9 11 64 102 999
-5 0 1 2 2 1 0 1 0 0 0 0 3 0
-1 0 1 1 2 0 0 2 5 38 65 831 999
.2 0 0 3 3 0 1 0 0 1 1 6 33 153
-3 0 1 2 0 0 1 0 3 3 0 2 0 1
-4 0 0 1 0 3 0 2 1 0 1 3 0 1
-5 0 1 0 0 2 0 1 0 0 0 1 2 0
-1 0 0 0 0 2 1 2 1 4 3 45 301 999
-2 0 0 2 0 1 0 1 1 0 1 1 0 0
-3 0 2 0 0 1 1 0 0 2 0 1 0 1
-4 0 2 1 0 0 1 1 0 0 1 0 0 1
-5 0 1 0 0 0 0 0 1 1 0 1 0 2
-1 0 1 0 3 0 3 1 1 9 19 194 999
.2 0 2 0 0 1 0 1 3 1 4 33 112 802
-3 0 0 2 0 3 0 1 1 2 0 0 0 0
-4 0 3 2 1 2 1 1 1 4 0 1 1 1
-5 0 0 1 2 1 0 0 0 3 0 1 0 0
-1 0 1 0 3 0 0 0 0 0 0 1 2 18
-2 0 1 2 0 2 0 1 1 1 0 1 1 1
-3 0 1 1 0 1 1 2 1 0 1 0 2 1
-4 0 2 4 1 0 0 0 0 0 2 0 0 0
-5 0 2 1 1 0 0 3 1 0 0 1 0 1
-1 0 0 0 0 0 1 0 0 0 0 0 4 0
-2 0 3 2 0 1 0 0 0 0 2 0 0 1
-3 0 3 2 0 1 2 1 0 0 0 0 0 0
-4 0 0 2 0 0 4 0 0 0 2 3 2 2
-5 0 1 0 1 1 0 2 0 1 2 1 0 0
-1 0 0 1 1 0 1 2 3 32 70 978 999
-2 0 2 2 1 0 0 2 1 10 19 218 999
-3 0 1 0 6 1 0 0 0 1 2 0 0 0
-4 0 2 0 0 0 0 1 0 0 0 2 1 1
-5 0 2 0 0 0 1 2 0 2 0 1 0 0
-1 0 2 0 0 3 0 1 1 0 0 1 0 0
-2 0 1 0 0 3 0 2 1 1 2 1 2 1
-3 0 1 1 0 2 0 1 0 1 0 0 1 2
-4 0 1 2 4 2 0 0 0 1 0 0 2 0
-5 0 1 1 0 1 3 4 0 3 0 0 1 1
-1 0 2 0 0 0 0 0 2 0 4 0 2 1
-2 0 1 2 0 0 0 1 0 1 0 0 1 0
-3 0 1 0 0 0 0 7 1 0 0 0 0 1
-4 0 0 1 0 0 0 1 0 3 0 0 1 2
-5 0 1 2 1 0 0 0 0 0 1 0 1 0
Conclusion :
STERANIOS 20 % CONCENTRE à 2,5 % réduit en 10 minutes la population de Mycobacte-
rium tuberculosis de 10^.
STERANIOS 20 % CONCENTRE à 5 % et à 10 % réduit en 5 minutes la population de Myco-
bacterium tuberculosis de
/(JZM*
L'essai a été réalisé selon la méthode d'essai décrite dans la norme européenne
EN 1275 « Antiseptiques et désinfectants chimiques - Activité fongicide de base».
Détermination de l'activité fongicide dans les conditions de laboratoire définies
par la présente norme européenne.
The test was realised according to the test method described in the
European standard EN 1275 « Antiseptics and chemical disinfectants».
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : B 011-06
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test température : 20°C±1°C
Temps de contact
Contact time : 5 minutes 110s
Température d'incubation
Incubation temperature : 30°C + 1°C
Pour les deux souches soumises à l'essai - For the both strains to be tested
N est compris entre 1,5 x 107 UFC/ml et 5 x 107 UFC/ml
is comprised between 1.5x10' CFU/mï and 5x10' CFU/ml
NV est compris entre 6 x 102 UFC/ml et 3 x 103 UFC/ml
is comprised between 6x10* CFU/ml and 3x10* CFU/ml
La neutralisation est validée avec le neutralisant testé pour la concentration d'essai de 10% du produit
STERANIOS 20% et pour les deux souches soumises à l'essai.
The neutralization is validated with the dilution neutralization method for the 10% test
concentration of the product STERANIOS 2O% and the strains tested.
Conclusion :
The test was realised according to the test method described in the European
standard EN 13624 « Chemical disinfectants and antiseptics- Quantitative
suspension test for the evaluation of fungicidal activity of chemical
disinfectants for instruments used in the medical area».
Determination of the fungicidal activity in the laboratory conditions defined in
the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 053-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test temperature : 20°C ± 1°C
Temps de contact
Contact time : 60 minutes ± 10s
Diluant du produit lors des essais : eau dure
Diluent of the product used during the test : hard water
Apparence du produit et de ses dilutions : préparation physiquement
homogène et stable pendant l'essai
Appearence product dilutions : Preparation physically
homogeneous and stable during test
Candida albicans 1.7 107 1.710e 4.8 4.8 101 6.3 101 6.5 101 6.9 101
Conclusion :
F. D
Responsable LappratBrne de Microbiologie Pharmacien Responsable Microbiologie
MicrobiologyLabc^aory Manager Pharmacist Microbiology Manager
The test was realised according to the test method described in the European
standard EN 13624 « Chemical disinfectants and antiseptics- Quantitative
suspension test for the evaluation of fungicidal activity of chemical
disinfectants for instruments used in the medical area».
Determination of the fungicidal activity in the laboratory conditions defined in
the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 053-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test température .......................................... : 20°C ± 1°C
Temps de contact
Contact tinte .................................................. : 5 minutes ± 10s
Diluant du produit lors des essais .................. : eau dure
Diluent of the product used during the test : hard water
Apparence du produit et de ses dilutions ...... : préparation physiquement
homogène et stable pendant l'essai
Appearence product dilutions...................: Preparation physically
homogeneous and stable during test
Candida albicans 1.7107 1.710',6 4.8 102 4.8 101 6.4 101 6.5 101 6.9 101
Conclusion :
F. raí
Responsable e Microbiologie Pharmacien Res sable Microbiologie
Microbi Manager Pharmacis; iology Manager
The test was realised according to the test method described in the European
standard EN 13624 « Chemical disinfectants and antiseptics- Quantitative
suspension test for the evaluation of fungicidal activity of chemical
disinfectants for instruments used in the medical area».
Determination of the fungicidal activity in the laboratory conditions defined in
the present European standard.
Nom du produit
Name of the product : STERANIOS 20%
Numéro de lot
Batch number : G 053-17
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test température : 20°C ± 1°C
Temps de contact
Contact time : 10 minutes ± 10s
Diluant du produit lors des essais : eau dure
Diluent of the product used during the test : hard water
Apparence du produit et de ses dilutions : préparation physiquement
homogène et stable pendant l'essai
Appearence product dilutions : Preparation physically
homogeneous and stable during test
Aspergillus niger 1.6 107 1.6106 4.710 2 4.7 101 3.1 101 3.1 101 3.0 101
Conclusion :
Laboratoires ANIOS
Pavé du Moulin
F-59260 Lille-Hellemmes
(http://www.anios.com)
Evaluation of the
effectiveness of
STERANIOS 20%
against
Bovine Viral Diarrhea Virus
(Surrogate of Hepatitis C Virus)
2005-10-19
1. Introduction
Examinations of virucidal activity of chemical disinfectants against hepatitis C virus (HCV)
are not possible, since there are no in vitro tests available. Therefore, bovine viral diarrhea
virus (BVDV) serves as a model virus, because this pestivirus also belongs to the family
Flaviviridae and has some properties similar to HCV (1,2). BVDV is a small ssRNA virus
with a nonsegmented positive strand and has before often used in blood product industry as a
surrogate of HCV.
This study was carried out in accordance with the guideline on testing chemical disinfectants
for effectiveness against viruses published by the Federal Office of Health (Bundesgesund-
heitsamt, BGA, now Robert Koch-Institute, Berlin, Germany) and the German Association for
the Control of Viruses Diseases (Deutsche Vereinigung zur Bekämpfung der Viruskrank-
heiten e.V., DVV) (3,4).
3. Identification of sample
4. Experimental conditions
were also performed with the interfering substances and with MicroSpin™ S-400 HR
columns.
6. Results
In parallel with the inactivation tests, cytotoxicity of STERANIOS 20% and 0.7%
formaldehyde was measured. The formaldehyde solution was toxic for the KOP-R cells in the
1:1000 dilutions. This corresponds to a logioCDso/mL of 4.50 (Table 1).
Examinations also showed that without treatment the instrument disinfectant STERANIOS
20% (5.0%) had a logioCD50/mL of 4.50 (cytotoxicity in thel:1000 dilution), whereas no
cytotoxic effect after treatment with the columns was measured resulting in a logioCDso/mL of
< 1.50 (Table 1).
These tests to measure cytotoxicity are imperative, because in this way the lower detection
threshold for non-inactivated BVDV is determined.
Virus titres without treatment with MicroSpin™ S-400 HR columns were 5.50 (assay without
protein load), 5.88 (assay with BSA) and 6.13 logioTCID50/mL (assay with PCS) (data not
shown in table).
Results of inactivation tests are found in table 2. Formaldehyde (0.7%) reduced the BVDV
titre after 5 minutes by 0.00 logio steps. After 15, 30 and 60 minutes RF's were > 1.00 (Table
2).
The instrument disinfectant STERANIOS 20% was examined as 5.0% solution. Exposure
times were 5, 15, 30 and 60 minutes.
Testing STERANIOS 20% as 5.0% solution, an efficacy was measured after an exposure time
of five minutes (Table 2). At this time, no BVDV was detectable any longer. The RFs were >
4.00 (assay without soil load), > 4.38 (assay with BSA) and > 4.13 (assay with PCS). This
corresponds in all cases to an inactivation of > 99.99%. According to the guideline of
BGA/DVV, a disinfectant or a disinfectant solution at a particular concentration is having
virus-inactivating efficacy if within the recommended exposure period the titre is reduced at
least by four logio.
Due to the lack of virological guidelines simulating practical conditions (phase2, step2) the
data of this quantitative suspension test lead to the recommendation to use the instrument
disinfectant STERANIOS 20% for inactivation of BVDV (surrogate of hepatitis C virus) as
follows:
5.0% 5 min
Dr. J. Steinmann
Literature
(O
I O i i i i T
0 . "P
_3 c
O
O
o
o
7(O W
c
s o <? 0 «?
*3 O '.= o l "P
"le 3 T- 3 i- c
'5. •u •o
(O
2
o
i
CM M
0 + + + + O I "P
c c
0)
n
•o b b l "P
c c
05
£
£0)
substance
substance
- 3 o ~ s
ö> £
o cd
ä?
^
^
o
£ o
S Ë1
C 'Í w o 'i c o Ü Ü |
(O ~
o o ö °
O 0) o
t t
+•*
<
Q¿
LLI
t-
(O
cone.
cone.
xp ^0 vp xP
'S ^
p
o^
q
a^
q N-
^
O O CJ h-
& LO LO iri CD
'5
'S
5 4-1
C «-> (D
c
r treatmen
re treatme
f
u "G t3 t3 "a t5 "G o -D o
•D
D 3 3 >>
T3 T3 TI •£ T3 "O "0 -C
o
l—
o
1_
o <u
l- T3 2 2 2 -g 'S
C
°- °- °- "rö Q. Q- 0. -J5
-•-• -•-• -!-• r—
to to to E (0
m
(0
m
(0
m
C
i— •q
RS OJ 0) 0) *-
£ •4-' -f-« -t~* O
ë -^ •*- *•• O c
0)
.n n
~ «
ii
? £
5 M- c O 0 o C 0
E m in in E in T3 T3 T3
(0 0 o c c c
o (Q CO VI VI VI CO VI
_J
E
"S
o
5 è
= o
c
ï (O
^
O) E
i/>
0
m
T
0
in
^
0
in
*
c
E
0
m
^r
TJ T3 T3
m C C C
0) ^ VI VI VI VI
¡
E i
o
* u¿
1 * c 0 0 o c 0
m
3 O
m in T3 T3
^^ O E T— E in C c C
10 VI VI VI m VI
p (O
o
CM '5.
W (O
g 2 •o CO CO
o
z .2 n & o "3 CO
s o o m ü_ o 0 m LL
2 ^
'5
.c
i
VP 0^
0
.n .c
i CM
xP ^P
0
P(0 E$ w
CM
0 ö 5
Ö o
reatme
U
g o
o o b b cd cd cd
'S 4-1
u iri in in 0
c c c
c
_o
"«
i
ro
¿>
0) JD
.> Ü E 0 J3
"ü 0
^S 0 o 0 T3 2 2 "2
co D 0 I
+1 2 3
T3 T3 T3 -C c c c c Q.
•o 2 2 2 0 o o o o Q.
Q. Q. CL
T3 o Ü Ü CO
O CO
to 'S) F 3 3 3 o •5
5 5 5
Q. W
0 0 0
_a> II II
"O CO
? c c
Ï oo
00 00
oo
oo
oo oo oo oo oo 0C o o
0 0 0 0 88 O 0 0 0 0 0 88 o o o o C C C 00 o o o o
oo 00 00
j/>
"05
t
00
0 0 0 0 o o o o 0 0 0 O O 0 o o o c 0 C 0 0 O C O O CO O o o o o
o o 88 88 o o o o o o o o o o o o o o o c o a o o o c o o 0 0 o o o o
.
|j oo oo oo oo oo oo oo oo 0C o oo o 0 C 0 0 co o
0 0 0 0 0 O 0 0 0 0 88 O 0 0 0 0 0 88 o c o a 0 0 8g o c o o CM CO 88 tu
Q_
O
^
Iî
(O
o o 00 0 0 00 o o o o0 0o o o ao c O
8 00 00
oo 00 88 o o o o o 00 00
o oo oo oo oo oooo oc
8S
Tí
0)
II
Tí Tí
o Iv',-; oo oo oo oo oo oo oo oo 00 oa
0 0 0 0 o o 0 0 0 0 88 0 0 0 0 0 0 o o o c 0 0 88 88 o o Tí
Tí Tí
Tí Tí Tí
O)
0)
-a
~|
oo oo oo oo
?«£ 88 00 o o
oo oo oo oo oo
88 o o o o 88 oaoo
88 88 o o o o 88 §8 o o o c 88 88 Si o c
oo oo oo oooo oc Tí Tí
Tf Tf
Tí Tí
«33 co
cu .!=
0) ;S'C¿Í -.-' i\\-
oo 0O oo oo oo
88 o o oo oo oo
88 o oo o oc o c ii
!! 33
Tí Tí
(O oo oo oo oo oo oa
ÍI
0C
88 00
o o 0 0 88
0 0 88 o o 0 0 88 88 o c 0 0 88 8§ o c
o o o o o o 88 o o o o o o o c o a o o o c o c
Tí Tí
Tí Tí
"O ü
•>$•'• W A
l;"-€ ., , ,'}i_ 00 00
oo
oo
8 8 88 88 0 0 O 0 88
oo oo oo oo oo
00 o o 0O O 0 00 o o
00 00 o o o a 0 0 0 0 0 C o c Tí
o o o o o o o c o a o o o c o c Tí
0 O 0 0 0 0 0 C o o 0 0 0 C 0 0 Tí
Tf
Tí
Tí
Tí Tí
33 33
Tí Tí
:
jjj: V^'-i
.¿t' -ai
o
m
CM
Ü&jIf-l *
»¿3 t
Lf> o o
CD IO 10 o o
CD to to
« o
CD
ro
c
ai ai
c.
CO 'x
o
o
1 ñ
1 CO <n lo
SSm
W
o
0.2% BSA
0a 0 ü o cu
o: 73
'15 a Ü- W
m
u. 73 LL
se
c0
3 csi
5?
o a. 5?
o en a?
CM 0
CO c
< c3 ó 0
f 0 0
rf^ "Ip
'vÄ1
^i - *'
Q
"^1
fc^' • «
¡/f
B
S s? S? ni
o
m 'vl? ^
$'~¡ 1O
to c
•D ro
":? - f.i
I ^ (D
Q. C
Q. O
CD ~a
^^¡;^i "o 'S
f^l c c
eranios 20%
/¡rus control
cytotoxicity
Ü^
Î ¿1 Í
fe'. ro T3
c c
c
O)
Q. co
Q.
K fi
pe '• C C c c C
fl ;Sf 8 8 O 0 0 O o o
«\fi*f^^'- . ííSIÍ^
u
o o
oo 0 0
;^Ay-j. • o o o o O 0 0
o o
o o
0
73
co
o.
'.OÉt.'-l
Ij-' •• oo o o o o
^8¿"-S 0 0
o o
8 8 1
oo O 0 0 0 8 8 C o
fiyfy ' -'"i • E
ifífíí* co
f:t|||') o o
88 8 8 0 O
o o 73 •5
?-: ? oo
CM O 8 8
0 0
o o o c C u>
0
^á w> ¿ 5
00
O 0 0 O O 0 o o 0O
o o
fc-fe*iK-
O O 0 0 0 0
oo
O CO
0 O
o o
8 8
O 0
o o 00
o ooo LU
0-
ü
!^3>l *'•
0 O o o o o 0 0
|:i^ • --¿ti'- o3 o o
0 0
0 0
o o
oo
O 0
^
0
O T- o o O 0 0 0 0O
D)
^^&>! ÎÇ*.
1
'•"', 0)
T3
gï||
íí; '*,; ' ««? :- £ £ £ i i ££ £ £ £ 0)1
jy-¥;S;, C) • S >
í;^?fe •',~;1A;<! So
', Í?'-' T.>í¿V-í
o c
Ül :titlí - £ *""
£ c
£
**
£ £ *"
£ €e
0) a
73 O
sï-Çs^.: 'í'ífiÍAJ
W Ä
^ílíí • fAÏ?.iî' E 0
'£"Js>,\ ii}^'
ÄJ5
> u
fe £"£ i i
£ t; £ £££
8^
o u 2
0 O T—
0
CM
fe .Í;¥;'?AC
2
4-1 10 o O!
m 0
CO
f
O :^ví2-^33 ,,£. '
u í'Éflíífe*'' ' ¿'- '<
0) 'W^^^ííijf^.f
•o o
'x
£ \;r|%^«i§y-| o
0) o
"re lá^Síe'' o
co CO II
m CO
Q. Û.
£ Í.AJO
*-
o ^ÍAX"
>" Ílfeví31ÍI
Q
m
"re
•o .¿:,g|"'," di dt S
5 á^.íc;*>;' - ' 0
2 5¿AÍJO,>,V ;
"o. c
o. o
CM CD 73
_0> 5%1Í,""**A.-' , 0 0
c c
SI (D cu
re •^ M" '~
u u
I- -,S**',t) . --.. j^ 1 -c"!2
X cu
5 f^É-í" "OÍ
S o
CÖ
C C
73
c - "44:'ÍS?' E E "*>*
£
Q.
'^',,'.IÍ¿, £ °
^'" ' u-til^.
Laboratory:
Extension: 251
Ref : JCD/VLJ/93007
SUBJECT OF REQUEST:
HEAD OF RESEARCH
Industrial Unit:
13, rue Lavoisier
92023 NANTERRE Cedex
Switchboard: +33 (0)1 47 29 13 13
Fax: +33 (0)1 47 25 36 02
Telex: 613 252 F SOLU AP
PRINCIPLE
The test was conducted in compliance with the protocol described in the approved French
standard NF T 72230: Water-miscible and neutralizable antiseptics and disinfectants used in
liquid state.
Determination of sporicidal activity. dilution-neutralisation method.
SAMPLE IDENTIFICATION
TEST CONDITIONS
Product diluent:
Neutralising agent:
CONCLUSION
The "STERANIOS 20% Concentré" product has sporicidal activity according to standard
AFNOR NF T 72230 with a 5-log reduction in 1 hour when diluted at 5% (v/v).
PHARMACIE CENTRALE
DES HÔPITAUX DE PARIS
Siège Social
7, rue du Fer-à-Moulin BP 09
75221 PARIS Cedex 05
Standard : 33 (1) 43 37 1100
Télécopie: 33 (1)43 37 95 97 Paris, le 16 Février 1993
Télex : 204 203 F PHARMAP
RESPONSABLE DE L'ETUDE
Laboratoire de Bactériologie
Unite Industrielle :
13, rue Lavoisier
92023 NANTERRE Cedex
Standard : 33 (1) 47 29 13 13
Télécopie : 33 (1) 47 25 36 02
Télex:613252FSOLUAP
PRINCIPE
L'essai a été réalisé selon le protocole décrit dans la norme française homologuée
et neutralisâmes.
IDENTIFICATION DE L'ECHANTILLON
CONDITIONS OPERATOIRES
Diluant du produit :
Neutralisant :
I« (/) §s ^j w'
o H 5 CO Q
Q>
3 m w ~"
CD 33
3 > eö'
CD
ZT O
(D W
5 1X3
O O
ro CD z
-g 55 CD
» O
i-§
— o
-
00 2
0§
</) c*
o rxj
""
-* —L -3
-vl
o
tu- *"
CD TJ
ro-
Q.
Gl cn c
CD o
0) 0" 5" 5'
O CQ CQ
Q.
CD- CD
W
ro CD
+ + "cn 3
O' s? -o
W
al
o -•• Q.
en cn I <T>
cp_ P N
o o? g 0
^
m
o3
i-*
Q)
-* O
o O o 0 -*
o^ 0)
3
CD
TI °
~z. P |00 en m
o S? W
ro -^
TI cn X 0
0 IV)
H S? <0 (0
^ W
m
w _
. . O
co _. o o
o o 10 0
-^
3
O
O) 0
<D
< 3
CD
O CD
ro U CJ
|0 O
lo Î5 0 O
¿^ 3 -vl
CO ™
cn T:
o o
CD < CD-
W ^
o o C5
CO
CO
CO
F. nd
Microbiologie Pharmacien sable Microbiologie
Manager Pharmaà obiology Manager
Nom du produit
Name of the product : STERANIOS20%
Numéro de formule
Batch formula : 03591 02
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test température : 20°C±1°C
Temps de contact
Contacttime : 60 minutes ± 10s
The pretest, leading to the choice of the most suitable neutralizing agent for
the application of this standard, shall be carried out before the main test.
c% SOUCHE - STRAIN N N1 nf
(v/v) collection d'origine et numéro
Original collection and number
10 Clostridium sporogenes CIP 7 939 188 199 211
Interprétation : Interpretation
X
SOUCHE - STRAIN N* X % (V/V) pH
1 2.5 5 7.5 10 xMin xMax
N' = Déterminé lors de l'essai préliminaire. Determined during the preliminary test
x = Concentration en % du produit en contact avec les micro-organismes.
Product concentration in contact with micro-organisms.
X = Dénombrement des micro-organismes survivants après contact avec le produit.
Counting of surviving micro-organisms after contact with the product
+ = Non numerable (+ de 150 colonies). Non countable (more than ISO colonies).
Interprétation :
Conclusion : Conclusion :
STERANIOS 20% présente une activité sporicide après 60 minutes de contact à
20°C, vis-à-vis de Clostridium sporogenes selon la norme NF T 72-231.
m rai
ResDofisable Microbiologie Pharmacien R™6nsable Microbiologie
Miaroogy Manager Fharm&tííst Microbiology Manager
L'essai a été réalisé selon le protocole fixé par la norme française expérimentale
T 72-301 "ANTISEPTIQUES et DESINFECTANTS UTILISES A L'ETAT LIQUIDE,
MISCIBLES A L'EAU".
Détermination de l'efficacité du produit sur divers micro-organismes dans les
conditions pratiques d'emploi.
Méthode par filtration sur membranes.
Nom du produit
Name of the product : STERANIOS 20%
Fabricant
Manufacturer : LABORATOIRES ANIOS
Température de l'essai
Test temperature : 20°C ± 1°C
Temps de contact
Contact time : 5 minutes et 15 minutest 10s
The pretest, leading to the choice of the most suitable neutralizing agent for
the application of this standard, shall be carried out before the main test.
c% SOUCHE - STRAIN N N1 n n1
(v/v) collection d'origine et numéro
Original collection and number
Interprétation : Interpretation
n, n', N1 et N sont équivalents (n1 > 0.5 N'), n, ri, N' arid N are equivalent (n1 >
0.5 N').
The bacterial suspensions are put into contact during 5 and 15 minutes at 20°C
with the product at different concentrations (x) and the suspension medium,
filtration through membranes, rinsing, counting of surviving micro-organisms.
The preliminary test and the actual test are simultaneously realised.
Temps de X
SOUCHE - STRAIN Nf contact X % (V/V) pH
contact 1 2.5 5 xMin xMax
time
Interprétation :
Sont sporicJdes, les concentrations pour lesquelles X < N'.
The sporicidal concentrations are those for which X <N'.
Conclusion : Conclusion :
STERANIOS 20% présente une activité sporicide sur les spores de Bacillus
cereus testées après 5 et 15 minutes de contact à 45°C, à la concentration de
5%, selon la norme T 72-301, dans un milieu de suspension composé d'albumine
0.3% et d'eau dure 30°f.
59260 LILLE-HELLEMMES
IN RABBIT
STERANIOS 20 % CONCENTRE
REPORT : 1C 93-313
I CONTENTS
I
Pages
1
1. INTRODUCTION
I
2. AUTHENTICATION OF THE STUDY
I
I 3. EXPERIMENTAL PROTOCOL 6
3.1. ANIMALS USED - HOUSING AND FEEDING 6
I 3.2. TEST CONDITIONS 7
3.3. MACROSCOPIC EXAMINATIONS AND EVALUATION OF THE PRIMARY
I CUTANEOUS IRRITATION 8
3.4. DETERMINATION OF THE PRIMARY CUTANEOUS IRRITATION INDEX 8
I
4. RESULTS - CONCLUSION 9
I 4.1. RESULTS 9
I 4.2. CONCLUSION 9
I
I
I
I
1
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 160
1C 93.313
SUMMARY OF TI STUDY
1. INTRODUCTION
STERANIOS 20 % CONCENTRE
To perform this trial, we received on March the 12th, 1993. sample with
the following characteristics :
. Colour : green
. pH : 4.1
attest that the study (Protocol BIOGIR S.A. REF. IC) was performed
according to the internal procedures, under the responsibility :
This study was carried out on the premises of BIOGIR S.A. Laboratory
(F 33611 GAZINET CEDEX).
All the documents related to this study are stored under the reference
1C 93-313 in special premises of BIOGIR S.A. Laboratory for three years.
At the end of this period, the study documents will be, after sponsor
agreement, either transferred in sponsor premises or destroyed.
3. EXPERIMENTAL PROTOCOL
The trial, performed between April the 6th and the 9th, 1993. was carried
out according to the protocol described below, established from the
official method as defined in the Decree of February 1st 1982 ("Journal
Officiel de la République Française", dated February 21st 1982),taking
into account the following modification :
3.1.1. Strain
3.1.2. Housing
The animals were identified on the day of their being placed in the
experiment by a numbered metal ring (CHEVILLOT-QUICK) clipped to the edge
of the ear (n° A 3730 to A 3732 and A 3763 to A 3765).
About 24 hours before the application of the product, the back and sides
of the rabbits were carefully clipped with a fine comb electric clipper
(height of cut : 0.1 mm) in order to obtain an area of skin of
approximately 14 x 14 cm.
On the left flank was applied the same way 0.5 ml of product on undamaged
skin area.
After application, the square gauzes were kept in contact with the skin,
using a hypoallergenic microporous adhesive strip 50 mm wide. The whole
was then covered with a stretchable band (fixed with an adhesive tape)
wrapped round the animal without any restrain for the respiratory and
abdominal movements.
Within one hour after the removal of the dressings, i.e. about 25 hours
and then 72 hours after the application of the product, macroscopic
observations were carried out for each rabbit, always under the same
conditions (particularly with regard to lighting).
The purpose of the observation was to evaluate both IRRITATION REACTIONS
on the treated areas comparatively to the control ones, according to the
following scale :
ERYTHEMA AND ESCHAR FORMATION
• No erythema 0
• Slight erythema (barely perceptible) 1
• Well defined erythema 2
• Substantial erythema 3
• Severe erythema (crimsom red) with or without eschar (deep
injuries) 4
If there was any doubt between two values of the evaluation scale, the
higher one was selected.
OEDEMA
No oedema.........................................................0
Very slight oedema (barely perceptible) ........................... 1
Slight oedema (edges of area well defined, apparent swelling) ..... 2
Moderate oedema (approximately 1 mm thick) ........................ 3
Severe oedema (more than 1 mm thick and extending beyond the
area of exposure).................................................4
On the other hand, structure modifications of the skin were noticed
(thickening, roughness, burn).
The scores obtained on the healthy and scarified skin for erythema and
oedema, 2k hours and 72 hours after application of the bandages, were
added together. The values thus obtained were divided by 24 (total number
of data) to obtain the Primary Cutaneous Irritation Index, designated as
IPc) . As from this index, the primary irritation reactions were
interpreted as follows :
1
1 4. RESULTS - CONCLUSION
1 4.1. RESULTS
1
•
The individual results
in the inclosed table.
scored according to the official scale are shown
1 index of 3-2.
4.2. CONCLUSION
1
• According to the adopted classification, and under the experimental
STERANIOS 20 % CONCENTRE
1
1 <T" r 1
-— ^
<^=^_JL_±=±^
1 Jean-François PIÑÓN
Pharmacologist Toxicologist Expert
1
1
1
1
s
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 167
1
• k RESULTATS : TABLEAU 1
• BIOGIRSjY. i (Results : Table 1)
1
• REF.PRODUIT : Stéranios 20% Concentré REF.ETUDE : 1C 93.3 13
(Product Ref.) (Study réf.)
• APPLICATION: 0.5 ml de solution du produit à 5% OPERATEUR: C. Scheyder
(Application) dans l'eau, sous pansement semi-occlusif (Operator)
1
JO le: 06/04/93
• (DO on)
1 LAPINN0 A A A A A A TOTAL
(Rabbit n°) 3763 3764 3765 3730 3731 3732
1
• E R Y T HE M E N 4 4 1 2 1 4 16
( E r y t h e En a ) 24h
1 S 4 4 2 2 2 4 18
N 4 4 0 1 0 4 13
• 72h
1 S 4 4 1 4 1 4 ! 18
O E D E M E N 0 2 0 0 0 2 4
1 ( 0 e d e m i<) 24h
• S 1 2 1 0 0 2 ¡1 6
N 0 0 0 0 0 0 0
1 72h
S 0 0 0 0 0 1 1 1
1 N S
1
1
f3'2
IPC = TOTAL(N)+TOTAL(S) =
24 • I
1
IRRITANT
1
1
1
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 168
I
I
I COMPANY : LABORATOIRES ANIOS
I Pavé du Moulin
59260 LILLE-HELLEMMES
I
I
I
I
I ASSESSMENT OF OCULAR IRRITATION
I IN RABBIT
STERANIOS 20 % CONCENTRE
I REPORT : 10 93-313
I
I
I
I
GAZINET, MAY 1993
GAZ1NET
Tél. : 56 68 02 S2
6 B 646 - Siret 33788201300C
CONTENTS
I
I
Pages
I
I SUMMARY OF THE STUDY
I 1. INTRODUCTION
I
3. EXPERIMENTAL PROTOCOL 6
• 4. RESULTS - CONCLUSION 11
4.1. RESULTS 11
• 4.2. CONCLUSION 11
I
I
I
I
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 170
l
I 10 93-313
I
I
I SUMMARY OF THE STUDY
I
I
I
I The product STERANIOS 20 % CONCENTRE 5 % diluted was instilled at the
single dose of 0.1 ml in the eye of three rabbits according to an
experimental protocol established from the official method as defined in
I
I
I
I
I
I
I
I
I Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 171
I
I 10 93.313
I
I 1. INTRODUCTION
I
I At the request of the LABORATOIRES ANIOS, Pavé du Moulin, 59260 LILLE-
HELLEMMES, we assessed on albino Rabbit the ocular irritation induced by
I the product :
I STERANIOS 20 % CONCENTRE
I To perform this trial, we received on March the 12th, 1993 a sample with
the following characteristics :
I Form
Colour
transparent liquid
green
I pH
I
I
I
I
I
I
I Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 172
I
I 10 93.313
I
I 2. AUTHENTICATION OF THE STUDY
I
I I the undersigned, J.François
Scientific director,
PIÑÓN, Master in Veterinarian Sciences,
I attest that the study (Protocol BIOGIR S.A. REF. 10) was performed
according to the internal procedures, under the responsibility :
I All the documents related to this study are stored under the reference
10 93'313 in special premises of BIOGIR S.A. Laboratory for three years.
I At the end of this period, the study documents will be, after sponsor
agreement, either transferred in sponsor premises or destroyed.
I The present
table.
report is made up of 11 pages numbered from 1 to 11 and 1
=1
I
I 3. EXPERIMENTAL PROTOCOL
I The trial, performed between April the 5th and the 12th, 1993 was carried
I out according to the official method as defined in the Decree of June the
9th 1992 ("Journal Officiel de la République Française", dated July the
10th 1992).
3.1.1. Strain
I 3 male albino New-Zealand rabbits, from the ELEVAGE DES FEUILLETAS (40 -
CAMPET LAMOLERE), about 12 weeks old at the start of the trial.
I 3.1.2. Housing
I The animals received tap water and food (UAR 112) ad libitum.
I
I
I
I
I
I
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 174
I
I 10 93.313
I
I 3.2. TEST CONDITIONS
I Prior to the trial, the animals were kept for an acclimatization period
of 10 days in the same conditions of quarters and feeding as those used
during the trial.
I The animals were identified on the day of their being placed in the
experiment by a numbered metal ring (CHEVILLOT-QUICK) clipped to the
edge of the ear (ne A 3730 to A 3732).
I Before the instillation, the eyes of the rabbits were inspected in order
to exclude animals showing ocular lesions.
I was applied 5 % diluted directly into the lower conjunctival sac of one
eye of each rabbit. The second eye was left untreated and served as a
control.
I Upper and lower eyelids were held in contact with each other for a few
seconds (10), in order to avoid any loss of product. Eyes were not rinsed.
I The animals were restrained for one hour before the first observation,
then were put back into their cages.
Ocular examinations were carried out in the following order and according
to the numerical scale of the "Journal Officiel de la République
I Française" dated 07-10.1992 : if there was any doubt between two values
of the evaluation scale, the higher one was selected.
I
I
I
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 175
i
I 10 93.313
I
I 3.3'1« Conjunctiva
I CHEMOSIS (Oedema)
I 0
0
0
No swelling
Slight swelling, including the nictating membrane
Swelling with eversión of the eyelids
0
1
2
I 0
No lacrymation
" Slight lacrymation
LACRYMATION
ENANTHEMA (redness)
I 0
Normal vessels
* Vessels definitely more injected than normally
0
1
I 0
Individual vessels not easily discerned :
- diffused bright red
- diffused dark red
2
3
I 3.3.2. Iris
Let C be the score obtained
I * Normal
* Markedly more folded than normal, congestion, swelling,
iris still reacting to light by contraction, even slow (any,
0
I 8
I
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 176
l
I 10 93.313
I
I 3.3.3. Cornea
I Except for the 1 hour reading and in order to verify the absence of
corneal and/or epithelial lesions and to assess the surface affected, one
I discernible
I
I OPACITY AFFECTED AREA and/or EPITHELIAL LESION
I
I
I
I
I
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 177
I
I 10 93.313
I
I 3.4. CALCULATION OF THE OCULAR IRRITATION INDICES
I . Conjunctiva : X = 2 x (A + B + C) (X a 20)
. Iris :Y = 5 x D (Y í 10)
I . Cornea :Z = 5 x E x F (Z ü 80)
I 1.0).
I From the value of the lOMax, the product was classified according to
the scale presented in the "J.O. de la République Française" dated 07-10,
I 1992 :
I lOMax CLASSIFICATION
I * 15
15 to s 30
SLIGHTLY IRRITANT
MODERATELY IRRITANT
I 30 to <, 50
> 50
IRRITANT
VERY IRRITANT
I
I 10
I
Laboratoires ANIOS - 000182 = Steranios 20% concentre
EN - Up-to-date version : 07-01-2008
Page 178
10 93-313
. RESULTS - CONCLUSION
4.1. RESULTS
4.2. CONCLUSION
STERANIOS 20 % CONCENTRE
Jean-François PIÑÓN
Pharmacologist Toxicologist Expert
11
The Safety Data Sheet (SDS) of this product is available on our Web site
www.anios.com. In addition to visualization and/or impression, it is possible
for you to download it.
The consultation of this SDS via internet enables you to receive later on by
email any updated version of this document.
Dilution Glutaraldehyde
concentration
5 % i.e.:
250 ml for 5 l 1%
500 ml for 10 l
10 % i.e.:
250 ml for 2.5 l 2%
500 ml for 5 l
1 Clean medical device with a 2 Rinse thoroughly with tap water. 3 Make the product dilution, according a
pre-disinfectant like ANIOSYME (Change rinsing water after every glutaraldehyde concentration required.
DD1, HEXANIOS G+R, use).
SALVANIOS pH7 or
ANIOSYME PLA.
4 Immerse the medical device. Cover 5 Rinse very thoroughly with 6 Dry with single-use tissue.
the soaking bath. Contact time: sterile or filtered water Keep medical device in an aseptic
10 minutes or 1 hour according to (0.2 µm). area.
Laboratoires ANIOS - 05a-0182GB
Pavé du Moulin
59260 Lille-Hellemmes . France
|
0459
Tel.: +33 3 20 67 67 67 AFAQ N°1995/3723a
Fax : +33 3 20 67 67 68